Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.11 USD | +1.14% | +4.41% | +17.13% |
Sales 2024 * | 2.67B 3.66B | Sales 2025 * | 2.79B 3.83B | Capitalization | 2.19B 3.01B |
---|---|---|---|---|---|
Net income 2024 * | -84M -115M | Net income 2025 * | 23M 31.6M | EV / Sales 2024 * | 1.7 x |
Net Debt 2024 * | 2.35B 3.23B | Net Debt 2025 * | 2.12B 2.92B | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 * |
-26.3
x | P/E ratio 2025 * |
102
x | Employees | 7,850 |
Yield 2024 * |
0.42% | Yield 2025 * |
-
| Free-Float | 26.13% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | +1.14% | ||
1 week | +4.41% | ||
Current month | +6.44% | ||
1 month | +6.76% | ||
3 months | +33.90% | ||
6 months | +53.23% | ||
Current year | +17.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | 11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | 11-06 |
J. Buchi
BRD | Director/Board Member | 69 | 11-06 |
Paul Meister
CHM | Chairman | 71 | 11-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 7.11 | +1.14% | 1,408,196 |
24-06-11 | 7.03 | +2.63% | 2,694,657 |
24-06-10 | 6.85 | +1.48% | 1,789,844 |
24-06-07 | 6.75 | +0.90% | 1,084,656 |
24-06-06 | 6.69 | -1.76% | 1,192,052 |
Delayed Quote Nasdaq, June 12, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.13% | 2.19B | |
+48.79% | 781B | |
+42.06% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.45% | 248B | |
+0.20% | 221B | |
+11.63% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- AMRX Stock